» Articles » PMID: 33995611

Recent Advances of Biomimetic Nano-systems in the Diagnosis and Treatment of Tumor

Overview
Date 2021 May 17
PMID 33995611
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The lack of effective methods of diagnosis and treatment presents a major barrier to combat against tumor. The biomimetic concept is an emerging field that expresses great application potential in tumor fighting. Strategy for combining nano-systems with biomimetic technology has gained increasing attention that is proved bioinspired, environmentally benign, and promising. Herein, we provide an up-to-date review of biomimetic nano-systems as well as their applications in tumor therapy. In addition, the challenges and future directions of biomimetic nano-systems to achieve clinical translation are also pointed out.

Citing Articles

Biomimetic Nanoparticle Based Targeted mRNA Vaccine Delivery as a Novel Therapy for Glioblastoma Multiforme.

Ahmed T, Alam K AAPS PharmSciTech. 2025; 26(3):68.

PMID: 39984771 DOI: 10.1208/s12249-025-03065-z.


Alkyl chain length-regulated intelligent nano-assemblies with AIE-active photosensitizers for photodynamic cancer therapy.

Shen L, Zhang Q, Yao Y, Huang Y, Zheng Z, Li M Asian J Pharm Sci. 2024; 19(6):100967.

PMID: 39640060 PMC: 11617974. DOI: 10.1016/j.ajps.2024.100967.


Nanoparticle-Mediated Drug Delivery Systems for Precision Targeting in Oncology.

Hristova-Panusheva K, Xenodochidis C, Georgieva M, Krasteva N Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931344 PMC: 11206252. DOI: 10.3390/ph17060677.


Recent advances in zwitterionic nanoscale drug delivery systems to overcome biological barriers.

Ouyang X, Liu Y, Zheng K, Pang Z, Peng S Asian J Pharm Sci. 2024; 19(1):100883.

PMID: 38357524 PMC: 10861844. DOI: 10.1016/j.ajps.2023.100883.


Metal organic framework-based variable-size nanoparticles for tumor microenvironment-responsive drug delivery.

Wang Y, Gao N, Li X, Ling G, Zhang P Drug Deliv Transl Res. 2024; 14(7):1737-1755.

PMID: 38329709 DOI: 10.1007/s13346-023-01500-x.


References
1.
Wang H, Agarwal P, Zhao S, Yu J, Lu X, He X . A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents. [Corrected]. Nat Commun. 2015; 6:10081. PMC: 4686774. DOI: 10.1038/ncomms10081. View

2.
Corbo C, Parodi A, Evangelopoulos M, Engler D, Matsunami R, Engler A . Proteomic Profiling of a Biomimetic Drug Delivery Platform. Curr Drug Targets. 2014; 16(13):1540-7. PMC: 4426090. DOI: 10.2174/1389450115666141109211413. View

3.
Ren D, Dalmau M, Randall A, Shindel M, Baldi P, Wang S . Biomimetic Design of Protein Nanomaterials for Hydrophobic Molecular Transport. Adv Funct Mater. 2013; 22(15):3170-3180. PMC: 3603581. DOI: 10.1002/adfm.201200052. View

4.
Lin T, Zhao P, Jiang Y, Tang Y, Jin H, Pan Z . Blood-Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy. ACS Nano. 2016; 10(11):9999-10012. DOI: 10.1021/acsnano.6b04268. View

5.
Felgner S, Kocijancic D, Frahm M, Curtiss 3rd R, Erhardt M, Weiss S . Optimizing Salmonella enterica serovar Typhimurium for bacteria-mediated tumor therapy. Gut Microbes. 2016; 7(2):171-7. PMC: 4856459. DOI: 10.1080/19490976.2016.1155021. View